SCHEMBL13507568

SCHEMBL13507568

Cc1ccc(N(c2ccccc2)c2ccc3c4c5ccc6c(c5ccc4n(C)c3c2)c2ccc(N(c3ccccc3)c3ccc(C)cc3)cc2n6C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.38
▸ ACHE P22303 2/20 0.38
▸ NQO2 P16083 1/20 0.35
▸ APP P05067 1/20 0.33
▸ SRC P12931 2/20 0.33
▸ TOP2A P11388 2/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HPGD P15428 3/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13506824 0.94 NQO2 (0.38) BCHEACHENQO2TOP2AKDM4E
SCHEMBL13506831 0.94 ALDH1A1 (0.35) BCHEACHENQO2TOP2AKDM4E
SCHEMBL13507575 0.89 MAOB (0.38) NQO2KDM4EALDH1A1MAPTCYP2C19
SCHEMBL13507560 0.87 TP53 (0.39) APPSRCTOP2AKDM4EALDH1A1
SCHEMBL13507561 0.86 NQO2 (0.33) NQO2TOP2AKDM4EALDH1A1MAPT
SCHEMBL21919228 0.85 GPR3 (0.48) BCHEACHENQO2SRCTOP2A
SCHEMBL13507026 0.85 KIF11 (0.38) BCHEACHENQO2KDM4EALDH1A1
SCHEMBL13506835 0.85 BCHE (0.33) BCHEACHENQO2APPMEN1
SCHEMBL18564817 0.84 NQO2 (0.37) NQO2TOP2AKDM4EALDH1A1MAPT
SCHEMBL13508148 0.84 KDM4E (0.41) TOP2AKDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 BCHE 2996/4885ACHE 552/4885NQO2 768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback